Also known as: Medidata
Medidata is a life sciences technology company providing digital platforms for clinical development and trial operations. It is a Dassault Systèmes company and supports global pharma, biotech, and medtech research workflows.
Medidata launched Medidata Plus, an AI-native foundation that unifies AI capabilities across the clinical trial lifecycle. The platform accelerates study builds, enables no-code data transformation, and supports 80% of FDA novel drug approvals in 2025.
AI is transforming decentralized clinical trials, with over $650 million in recent funding and threefold faster patient recruitment. Experts warn that AI-optimized protocols may still struggle to recruit patients, emphasizing lean trial design and adaptive planning.
The global AI in clinical trials market is expected to grow from $2.09 billion currently to $18.62 billion by 2040, driven by enhanced patient recruitment, optimized trial designs, and automation that reduces time and costs in drug development.
Artificial intelligence emerged as the dominant topic in clinical research during 2025, with applications spanning operational efficiency, drug discovery, and patient recruitment, though no AI-discovered drug has yet achieved FDA marketing approval.
SCOPE 2026 in Orlando recognized innovation in clinical research with three awards programs, honoring Biogen's lupus webinar series, TrialScreen's site connection initiative, and Biorce's AI platform among 70 competing products.
